The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials
COVID-NMA is an international research initiative supported by the WHO and Cochrane.
We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on vaccines, preventive interventions and treatments for COVID-19 to assist decision makers.
For 2023, COVID-NMA revised its protocol and reduced its scope.
- For the living mapping, we continue to update and include all COVID-19 vaccine trials only.
- For the living evidence synthesis, we continue to update only COVID-19 vaccines boosters.
See the description of our model here and our living review protocol here.
LIVING MAPPING OF TRIALS(i.e., trials registered on Clinicaltrials.gov and EU clinical trials registries
982 RCTs recruiting
LIVING SYNTHESIS OF PUBLISHED STUDIES((include both journals published and preprints)
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis
April 1,2023 to April 28, 2023. See the update here.
To receive updates on our project, please subscribe below.
Download CSV file (last update: 2023-04-21).
Download CSV file (last update: 2022-09-15).